KELEDJIAN HAIG 4

4 · VIRAL GENETICS INC /DE/ · Filed Oct 21, 2004

Insider Transaction Report

Form 4

Period: 2004-06-04

VIRAL GENETICS INC /DE/VRAL

KELEDJIAN HAIG

DirectorCEO10% Owner

Transactions

Award
common stock
[F1]
2004-09-20+1,192,970→ 20,510,630 total
Other
common stock
[F1]
2004-09-20+4,986,600→ 20,510,630 total(indirect: By Trust)
Other
common stock
[F1]
2004-09-20+1,817,521→ 20,510,630 total(indirect: Held by Bretton Securities UDT 07/20/95)
Other
common stock
[F1]
2004-09-20+1,850,466→ 20,510,630 total(indirect: By Trust)
Other
common stock
[F1]
2004-09-20+9,884→ 20,510,630 total(indirect: By Foundation)
Award
Employee Stock Option
[F3][F2]
2004-06-04+1,800,000→ 4,100,000 total
Exercise: $0.45Exp: 2008-05-31→ common stock (1,800,000 underlying)
Other
Convertible Notes Due
[F4][F5][F2]
2004-08-05(indirect: Notes held by Best Investments, Inc.)
Exercise: $0.30Exp: 2008-05-31→ common stock (4,725,708 underlying)
Other
common stock warrant
[F4][F5][F2]
2004-08-05+4,725,708→ 4,725,708 total(indirect: Held by Best Investments, Inc.)
Exercise: $0.40Exp: 2008-05-31→ common stock (4,725,708 underlying)
Award
stock option
[F6][F5][F2]
2004-09-20+24,140→ 199,473 total
Exercise: $0.52Exp: 2006-09-19→ common stock (24,140 underlying)
Other
stock option
[F5][F2]
2004-09-20+100,908→ 199,473 total(indirect: By Trust)
Exercise: $0.52Exp: 2006-09-19→ common stock (100,908 underlying)
Other
stock option
[F5][F2]
2004-09-20+36,779→ 199,473 total(indirect: held by Bretton Securities UDT 07/20/1995)
Exercise: $0.52Exp: 2006-09-19→ common stock (36,779 underlying)
Other
stock option
[F5][F2]
2004-09-20+37,446→ 199,473 total(indirect: By Trust)
Exercise: $0.52Exp: 2006-09-19→ common stock (37,446 underlying)
Other
stock option
[F5][F2]
2004-09-20+200→ 199,473 total(indirect: By Foundation)
Exercise: $0.52Exp: 2006-09-19→ common stock (200 underlying)
Award
stock option
[F2]
2004-09-20+12,070→ 99,737 total
Exercise: $0.38Exp: 2006-09-19→ common stock (12,070 underlying)
Other
stock option
[F5][F2]
2004-09-20+50,454→ 90,737 total(indirect: By Trust)
Exercise: $0.38Exp: 2006-09-19→ common stock (50,454 underlying)
Other
stock option
[F5][F2]
2004-09-20+18,390→ 99,737 total(indirect: held by Bretton Securities UDT 07/20/1995)
Exercise: $0.38Exp: 2006-09-19→ common stock (18,390 underlying)
Other
stock option
[F5][F2]
2004-09-20+18,723→ 99,737 total(indirect: By Trust)
Exercise: $0.38Exp: 2006-09-19→ common stock (18,723 underlying)
Other
stock option
[F5][F2]
2004-09-20+100→ 99,737 total(indirect: By Foundation)
Exercise: $0.38Exp: 2006-09-19→ common stock (100 underlying)
Award
stock option
[F5][F2]
2004-09-20+12,070→ 99,737 total
Exercise: $0.65Exp: 2006-09-19→ common stock (12,070 underlying)
Other
stock option
[F5][F2]
2004-09-20+50,454→ 99,737 total(indirect: By Trust)
Exercise: $0.65Exp: 2006-09-19→ common stock (50,454 underlying)
Other
stock option
[F5][F2]
2004-09-20+18,390→ 99,737 total(indirect: held by Bretton Securities UDT 07/20/1995)
Exercise: $0.65Exp: 2006-09-19→ common stock (18,390 underlying)
Other
stock option
[F5][F2]
2004-09-20+18,723→ 99,737 total(indirect: By Trust)
Exercise: $0.65Exp: 2006-09-19→ common stock (18,723 underlying)
Other
stock option
[F5][F2]
2004-09-20+100→ 99,737 total(indirect: By Foundation)
Exercise: $0.65Exp: 2006-09-19→ common stock (100 underlying)
Award
stock option
[F5][F2]
2004-09-20+12,070→ 99,737 total
Exercise: $0.58Exp: 2006-09-19→ common stock (12,070 underlying)
Other
stock option
[F5][F2]
2004-09-20+50,454→ 99,737 total(indirect: By Trust)
Exercise: $0.58Exp: 2006-09-19→ common stock (50,454 underlying)
Other
stock option
[F5][F2]
2004-09-20+18,390→ 99,737 total(indirect: held by Bretton Securities UDT 07/20/1995)
Exercise: $0.58Exp: 2006-09-19→ common stock (18,390 underlying)
Other
stock option
[F5][F2]
2004-09-20+18,723→ 99,737 total(indirect: By Trust)
Exercise: $0.58Exp: 2006-09-19→ common stock (18,723 underlying)
Other
stock option
[F5][F2]
2004-09-20+100→ 99,737 total(indirect: By Foundation)
Exercise: $0.58Exp: 2006-09-19→ common stock (100 underlying)
Award
common stock warrant
[F7][F5][F2]
2004-09-20+1,192,970→ 9,857,441 total
Exercise: $0.40Exp: 2009-09-19→ common stock (1,192,970 underlying)
Other
common stock warrant
[F7][F5][F2]
2004-09-20+4,986,600→ 9,857,441 total(indirect: By Trust)
Exercise: $0.40Exp: 2009-09-19→ common stock (4,986,600 underlying)
Other
common stock warrant
[F7][F5][F2]
2004-09-20+1,817,521→ 9,857,441 total(indirect: held by Bretton Securities UDT 07/20/1995)
Exercise: $0.40Exp: 2009-09-19→ common stock (1,817,521 underlying)
Other
common stock warrant
[F7][F5][F2]
2004-09-20+1,850,466→ 9,857,411 total(indirect: By Trust)
Exercise: $0.40Exp: 2009-09-19→ common stock (1,850,466 underlying)
Other
common stock warrant
[F7][F5][F2]
2004-09-20+9,884→ 9,857,441 total(indirect: By Foundation)
Exercise: $0.40Exp: 2009-09-19→ common stock (9,884 underlying)

Footnotes (7)

[F1]Received in exchange for capital stock of Therapeutic Genetic, Inc., in connection with merger of Therapeutic Genetic, Inc. into subsidiary of Viral Genetics, Inc. On September 20, 2004, the high bid price for Viral Genetics, Inc. common stock in the over-the-counter market was $0.38.
[F2]immediately
[F3]granted pursuant to Employment Agreement
[F4]Convertible notes held by Hampar Karageozian and Harry Zhabilov, Jr., were contributed to Best Investments, Inc., together with a convertible note held by Haig Keledjian. Mr. Keledjian is the sole officer and director of Best Investments, Inc., but disclaims any pecuniary interest in the convertible notes contributed by others. Upon conversion, the holder receives one share and one warrant per $0.30 of principal and interest.
[F5]not applicable
[F6]All stock options with a transaction date of 09/20/2004 are options originally granted to Therapeutic Genetic, Inc. and distributed by Therapeutic Genetic, Inc. to its shareholders for no consideration immediately prior to the merger of Therapeutic Genetic, Inc. with the subsidiary of Viral Genetics, Inc.
[F7]The warrants were issued with common stock of Viral Genetics, Inc. in the merger transaction that resulted in the acquisition of Therapeutic Genetic, Inc.

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT